dm+d
414804006
Lactation Safety Information
No alternative for stage of multiple sclerosis for which used
Limited published evidence shows variable levels in breast milk, ranging from undetectable to moderate.
The long half-life increases the risk of accumulation
Natalizumab is a very large protein molecule which is likely to be degraded in the infant’s gastro-intestinal tract. Very limited published evidence shows infant serum levels are undetectable.
As a precaution, the infant should be monitored for signs of infection, changes in feeding and poor weight gain.
Breastfeeding appears to have beneficial effects to a mother with multiple sclerosis
15 March 2022